This site is intended for healthcare professionals only

PCRA Logo

ILD series part 3: treatment options and considerations

Posted on: 5 Nov 2019
 

This video will focus on the treatment options and considerations in interstitial lung disease.

  • Identify treatment options for inflammatory-type ILD
  • Understand the different treatment considerations for inflammatory and fibrotic forms of ILD
  • Identify non-drug treatments and other therapies for ILD

If you have any feedback or comments, please email: respiratoryacademy@cogora.com

Please note that the RCN cannot confirm the competence of any practitioner.

Download: Video evaluation form Download: Reflective learning log Download: Video transcription Download: Video slides - Treatment options and considerations



Other videos in this series


Author: Boehringer Ingelheim
ILD series part 1: identification and patient referral
CPD points
13min 11sec
Author: Boehringer Ingelheim
ILD series part 2: diagnosis and testing
CPD points
13min 44sec
Author: Boehringer Ingelheim
ILD series part 4: end of life care
CPD points
08min 48sec
Author: Circassia
Implementing FeNO testing in primary care: successes and lessons
CPD points
24min 51sec


Media partners


Sponsors

Boehringer Logo

Community Pharmacy Platform sponsor

Boehringer Logo

Community Pharmacy Platform sponsor

GSK Logo

Clinical and Commissioning
Platform sponsor

Orion Pharma Logo

Commissioning Platform sponsor

The Primary Care Respiratory Academy has been developed and is produced by Cogora, the publisher of Pulse, Nursing in Practice, Healthcare Leader, Management in Practice and The Pharmacist working in partnership with PCRS. All educational content for the website and Roadshows, unless specified as sponsored content, has been initiated and produced by PCRS/Cogora.